Cargando…
Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma
Background: Hepatitis B virus (HBV) infection is one of the major causes of chronic liver disease, which progresses from chronic hepatitis B (CHB) to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Early detection and laboratory-based screening of hepatocellular carcinoma are still major ch...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429180/ https://www.ncbi.nlm.nih.gov/pubmed/37593116 http://dx.doi.org/10.3389/fgene.2023.1235260 |
_version_ | 1785090646325854208 |
---|---|
author | Kumar, Sonu Nadda, Neeti Quadri, Afnan Kumar, Rahul Paul, Shashi Tanwar, Pranay Gamanagatti, Shivanand Dash, Nihar Ranjan Saraya, Anoop Shalimar Nayak, Baibaswata |
author_facet | Kumar, Sonu Nadda, Neeti Quadri, Afnan Kumar, Rahul Paul, Shashi Tanwar, Pranay Gamanagatti, Shivanand Dash, Nihar Ranjan Saraya, Anoop Shalimar Nayak, Baibaswata |
author_sort | Kumar, Sonu |
collection | PubMed |
description | Background: Hepatitis B virus (HBV) infection is one of the major causes of chronic liver disease, which progresses from chronic hepatitis B (CHB) to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Early detection and laboratory-based screening of hepatocellular carcinoma are still major challenges. This study was undertaken to determine whether the cancer hallmark gene signatures that are released into circulation as circulating tumour DNA (ctDNA) can be used as a liquid biopsy marker for screening, early detection, and prognosis of HCC. Methods: A total of 130 subjects, including HBV-HCC (n = 80), HBV-cirrhotic and non-cirrhotic (n = 35), and healthy (n = 15) controls, were evaluated for TP53 and beta-catenin (CTNNB1) gene hotspot mutations in ctDNA by Sanger-based cycle sequencing and droplet digital PCR (ddPCR) assays. Mutation detection frequency, percentage mutant fractions, and their association with tumour stage, mortality, and smoking habits were determined. Results: Sanger-based cycle sequencing was carried out for 32 HCC patients. Predict SNP Tools analysis indicated several pathogenic driver mutations in the ctDNA sequence, which include p.D228N, p.C229R, p.H233R, p.Y234D, p.S240T, p.G245S, and p.R249M for TP53 gene exon 7 and p.S33T for CTNNB1 gene exon 3. The TP53 c.746G>T (p.R249M) mutation was detected predominately (25% cases) by sequencing, but there was no dominant mutation at position c.747G>T (p.R249S) that was reported for HBV-HCC patients. A dual-probe ddPCR assay was developed to determine mutant and wild-type copy numbers of TP53 (p.R249M and p.R249S) and CTNNB1 (p.S45P) and their percentage mutant fraction in all 130 subjects. The TP53 R249M and CTNNB1 S45P mutations were detected in 31.25% and 26.25% of HCC patients, respectively, with a high mutant-to-wild-type fraction percentage (1.81% and 1.73%), which is significant as compared to cirrhotic and non-cirrhotic patients. Poor survival was observed in HCC patients with combined TP53 and CTNNB1 gene driver mutations. The TP53 R249M mutation was also significantly (p < 0.0001) associated with smoking habits (OR, 11.77; 95% CI, 3.219–36.20), but not the same for the TP53 R249S mutation. Conclusion: Screening of ctDNA TP53 and CTNNB1 gene mutations by ddPCR may be helpful for early detection and identifying the risk of HCC progression. |
format | Online Article Text |
id | pubmed-10429180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104291802023-08-17 Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma Kumar, Sonu Nadda, Neeti Quadri, Afnan Kumar, Rahul Paul, Shashi Tanwar, Pranay Gamanagatti, Shivanand Dash, Nihar Ranjan Saraya, Anoop Shalimar Nayak, Baibaswata Front Genet Genetics Background: Hepatitis B virus (HBV) infection is one of the major causes of chronic liver disease, which progresses from chronic hepatitis B (CHB) to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Early detection and laboratory-based screening of hepatocellular carcinoma are still major challenges. This study was undertaken to determine whether the cancer hallmark gene signatures that are released into circulation as circulating tumour DNA (ctDNA) can be used as a liquid biopsy marker for screening, early detection, and prognosis of HCC. Methods: A total of 130 subjects, including HBV-HCC (n = 80), HBV-cirrhotic and non-cirrhotic (n = 35), and healthy (n = 15) controls, were evaluated for TP53 and beta-catenin (CTNNB1) gene hotspot mutations in ctDNA by Sanger-based cycle sequencing and droplet digital PCR (ddPCR) assays. Mutation detection frequency, percentage mutant fractions, and their association with tumour stage, mortality, and smoking habits were determined. Results: Sanger-based cycle sequencing was carried out for 32 HCC patients. Predict SNP Tools analysis indicated several pathogenic driver mutations in the ctDNA sequence, which include p.D228N, p.C229R, p.H233R, p.Y234D, p.S240T, p.G245S, and p.R249M for TP53 gene exon 7 and p.S33T for CTNNB1 gene exon 3. The TP53 c.746G>T (p.R249M) mutation was detected predominately (25% cases) by sequencing, but there was no dominant mutation at position c.747G>T (p.R249S) that was reported for HBV-HCC patients. A dual-probe ddPCR assay was developed to determine mutant and wild-type copy numbers of TP53 (p.R249M and p.R249S) and CTNNB1 (p.S45P) and their percentage mutant fraction in all 130 subjects. The TP53 R249M and CTNNB1 S45P mutations were detected in 31.25% and 26.25% of HCC patients, respectively, with a high mutant-to-wild-type fraction percentage (1.81% and 1.73%), which is significant as compared to cirrhotic and non-cirrhotic patients. Poor survival was observed in HCC patients with combined TP53 and CTNNB1 gene driver mutations. The TP53 R249M mutation was also significantly (p < 0.0001) associated with smoking habits (OR, 11.77; 95% CI, 3.219–36.20), but not the same for the TP53 R249S mutation. Conclusion: Screening of ctDNA TP53 and CTNNB1 gene mutations by ddPCR may be helpful for early detection and identifying the risk of HCC progression. Frontiers Media S.A. 2023-08-01 /pmc/articles/PMC10429180/ /pubmed/37593116 http://dx.doi.org/10.3389/fgene.2023.1235260 Text en Copyright © 2023 Kumar, Nadda, Quadri, Kumar, Paul, Tanwar, Gamanagatti, Dash, Saraya, Shalimar and Nayak. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Kumar, Sonu Nadda, Neeti Quadri, Afnan Kumar, Rahul Paul, Shashi Tanwar, Pranay Gamanagatti, Shivanand Dash, Nihar Ranjan Saraya, Anoop Shalimar Nayak, Baibaswata Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title | Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title_full | Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title_fullStr | Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title_full_unstemmed | Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title_short | Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma |
title_sort | assessments of tp53 and ctnnb1 gene hotspot mutations in circulating tumour dna of hepatitis b virus-induced hepatocellular carcinoma |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429180/ https://www.ncbi.nlm.nih.gov/pubmed/37593116 http://dx.doi.org/10.3389/fgene.2023.1235260 |
work_keys_str_mv | AT kumarsonu assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT naddaneeti assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT quadriafnan assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT kumarrahul assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT paulshashi assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT tanwarpranay assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT gamanagattishivanand assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT dashniharranjan assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT sarayaanoop assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT shalimar assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma AT nayakbaibaswata assessmentsoftp53andctnnb1genehotspotmutationsincirculatingtumourdnaofhepatitisbvirusinducedhepatocellularcarcinoma |